Antisaccadic eye movements in middle-aged individuals with a family history of Alzheimer's disease

被引:0
|
作者
Peng, Anjiao [1 ]
Lai, Wanlin [1 ]
Liu, Zhu [1 ]
Wang, Mingda [2 ]
Chen, Shujuan [2 ]
Zhao, Xia [2 ]
Zhu, Yuanfeng [2 ]
Chen, Lei [1 ]
机构
[1] Sichuan Univ, West China Hosp, Joint Res Inst Altitude Hlth, Dept Neurol, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Clin Res Management, Chengdu, Sichuan, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
eye tracking; Alzheimer's disease; neurodegenerative diseases; cognition; antisaccade; BRAIN ACTIVATION; SACCADE DEFICITS; GENETIC RISK; PATTERNS; PEOPLE;
D O I
10.3389/fnhum.2023.1143690
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BackgroundAntisaccade is closely associated with cognitive ability in Alzheimer's disease (AD). However, studies regarding antisaccade in the early stages of AD are scarce. Considering that first-degree family history is a well-established risk factor for AD, we explored the influence of family history on the performance of antisaccade tasks in individuals with normal cognition. MethodsIn total, 44 participants (aged 50-66 years) with a family history of AD (FH+) and 44 age-, gender-, and educational level-matched controls (FH-) were enrolled in our study. After cognitive assessment using the Montreal Cognitive Assessment and Mini-mental State Examination, participants underwent antisaccade trials, and all parameters were recorded using an eye tracker. ResultsWhile the average velocity was relatively lower in FH+ individuals than in FH- individuals (107.9 +/- 14.3 degrees/s vs. 132.9 +/- 23.7 degrees/s, p < 0.001), FH+ individuals surprisingly showed relatively fewer uninhibited reflexive saccades (44.7 +/- 26.0% vs. 56.2 +/- 24.7%, p = 0.037) than the control group. They also required a relatively shorter time to detect and correct false saccades (121.6 +/- 40.7 ms vs. 143.9 +/- 37.0 ms, p = 0.023). ConclusionsThis study showed that family history is associated with alterations in antisaccadic parameters, suggesting that eye tracking can be used to assess oculomotor control and executive function in individuals at risk of developing dementia.
引用
收藏
页数:6
相关论文
共 50 条
  • [42] Amyloid Burden, Neuronal Function, and Cognitive Decline in Middle-Aged Adults at Risk for Alzheimer's Disease
    Okonkwo, Ozioma C.
    Oh, Jennifer M.
    Koscik, Rebecca
    Jonaitis, Erin
    Cleary, Caitlin A.
    Dowling, N. Maritza
    Bendlin, Barbara B.
    LaRue, Asenath
    Hermann, Bruce P.
    Barnhart, Todd E.
    Murali, Dhanabalan
    Rowley, Howard A.
    Carlsson, Cynthia M.
    Gallagher, Catherine L.
    Asthana, Sanjay
    Sager, Mark A.
    Christian, Brad T.
    Johnson, Sterling C.
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2014, 20 (04) : 422 - 433
  • [43] Cerebrospinal fluid levels of Alzheimer's disease biomarkers in middle-aged patients with type 1 diabetes
    Ouwens, D. Margriet
    van Duinkerken, Eelco
    Schoonenboom, S. Niki M.
    de Wiza, Daniella Herzfeld
    Klein, Martin
    van Golen, Larissa
    Pouwels, Petra J. W.
    Barkhof, Frederik
    Moll, Annette C.
    Snoek, Frank J.
    Teunissen, Charlotte E.
    Scheltens, Philip
    Diamant, Michaela
    DIABETOLOGIA, 2014, 57 (10) : 2208 - 2214
  • [44] Analyzing Facial and Eye Movements to Screen for Alzheimer's Disease
    Nam, Uiseo
    Lee, Kunyoung
    Ko, Hyunwoong
    Lee, Jun-Young
    Lee, Eui Chul
    SENSORS, 2020, 20 (18)
  • [45] Cerebrospinal fluid levels of Alzheimer’s disease biomarkers in middle-aged patients with type 1 diabetes
    D. Margriet Ouwens
    Eelco van Duinkerken
    S. Niki M. Schoonenboom
    Daniella Herzfeld de Wiza
    Martin Klein
    Larissa van Golen
    Petra J. W. Pouwels
    Frederik Barkhof
    Annette C. Moll
    Frank J. Snoek
    Charlotte E. Teunissen
    Philip Scheltens
    Michaela Diamant
    Diabetologia, 2014, 57 : 2208 - 2214
  • [46] Saccadic Eye Movements and Attentional Control in Alzheimer's Disease
    Noiret, Nicolas
    Carvalho, Nicolas
    Laurent, Eric
    Chopard, Gilles
    Binetruy, Mickael
    Nicolier, Magali
    Monnin, Julie
    Magnin, Eloi
    Vandel, Pierre
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2018, 33 (01) : 1 - 13
  • [47] CSF biomarkers correlate with working memory in middle-aged adults at risk for Alzheimer's disease.
    Carlsson, C. M.
    Gleason, C. E.
    Barnet, J. H.
    Blazel, H. M.
    Johnson, S. C.
    Atwood, C. S.
    Puglielli, L.
    Hermann, B. R.
    Sager, M. A.
    Asthana, S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S13 - S13
  • [48] Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease
    Carlsson, Cynthia M.
    Gleason, Carey E.
    Hess, Timothy M.
    Moreland, Kimberly A.
    Blazel, Hanna M.
    Koscik, Rebecca L.
    Schreiber, Nathan T. N.
    Johnson, Sterling C.
    Atwood, Craig S.
    Puglielli, Luigi
    Hermann, Bruce P.
    McBride, Patrick E.
    Stein, James H.
    Sager, Mark A.
    Asthana, Sanjay
    JOURNAL OF ALZHEIMERS DISEASE, 2008, 13 (02) : 187 - 197
  • [49] Kinesiophobia And White Matter Integrity In Sedentary Middle-Aged Adults At Heightened Risk For Alzheimer's Disease
    Slutsky-Ganesh, Alexis B.
    Etnier, Jennifer L.
    DuBois, Samantha L.
    Park, Kyoungshin S.
    Vance, Jarod
    Som-Pimpong, Hadassah
    Kibildis, Sam W.
    O'Brokta, Megan M.
    Armstrong, Brittany D.
    Hugenschmidt, Christina E.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 166 - 166
  • [50] Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease
    Xiong, Chengjie
    McCue, Lena M.
    Buckles, Virginia
    Grant, Elizabeth
    Agboola, Folasade
    Coble, Dean
    Bateman, Randall J.
    Fagan, Anne M.
    Benzinger, Tammie L. S.
    Hassenstab, Jason
    Schindler, Suzanne E.
    McDade, Eric
    Moulder, Krista
    Gordon, Brian A.
    Cruchaga, Carlos
    Day, Gregory S.
    Ikeuchi, Takeshi
    Suzuki, Kazushi
    Allegri, Ricardo F.
    Voeglein, Jonathan
    Levin, Johannes
    Morris, John C.
    ALZHEIMERS & DEMENTIA, 2023, 19 (07) : 2923 - 2932